The Regulation organises the parentage testing workflow into distinct, legally significant stages: identity verification, sample collection, chain of custody and labelling, transport and storage, laboratory testing under accreditation, time limits for testing, and formal reporting. Each of those stages is underpinned by prescriptive micro-rules.

Identity verification and consent architecture. Section 6 prescribes an affidavit in an approved form made by a "relevant person" for the donor, two recent photographs meeting the approved-form requirements, and a particular method of signing partly on the photograph and partly on the affidavit. The term "relevant person" is defined in s 6 to capture the donor in ordinary cases, and to expand to persons authorised to consent for children under 16, children aged 16 or 17 with impaired capacity, and adults with impaired capacity, by cross-reference to s 11(4)(b) and (c) of the Act. The Regulation therefore embeds the Act’s consent rules into the identity-verification step.

Sampler exclusivity and qualifications. Section 5 provides the simple but absolute rule that only a "sampler" may take a sample for a parentage testing procedure. The meaning of "sampler" is not set out in the text reproduced here, instead it will appear in Schedule 1 (s 3). The exclusivity rule allocates decision authority and responsibility for proper sampling procedures to a legally defined class of persons.

Instrument and hygiene standards. Sections 7 and 8 impose single-use, sterilisation and disposal requirements for instruments used to take blood and other biological samples for DNA typing. For blood, the instrument must not have been previously used for any purpose, must be sterilised and disposable, and the skin must be cleaned with antiseptic prior to puncture (s 7). For non-blood DNA sampling, swabs must be unused and sterilised, and skin scrapings and hair roots must be taken using a sterilised implement (s 8). These are procedural safeguards directed at minimising contamination risk and supporting the evidentiary integrity of the sample.

Chain of custody, labelling and witness requirements. Section 9 mandates immediate placement of the sample in a container in the presence of a relevant person, use of a previously unused container that is sealed in a tamper-evident manner, and attachment of a label that itself is tamper-evident in the sense that removal or alteration would be obvious on inspection. The label must be written in ink with the donor’s full name, sex and date of birth, the date and time of the sample, and the sampler and relevant person must sign the label in ink after those entries are made. Section 10 adds that the sampler must make a statement in the approved form, attach one of the photographs mentioned in s 6 to that statement, and sign partly on the photograph and partly on the statement in the manner required by the approved form.

Sample preservation, documentation and laboratory handover. Section 11 requires samplers to ensure storage, packing and transport preserve the integrity of the sample and ensure that testing will produce the same results as if performed immediately after collection. The sampler must also send the affidavit and the sampler’s statement to the accredited laboratory with the sample. Section 12 requires that testing occur only at an accredited laboratory and under the standards of practice for which that laboratory holds accreditation. Section 13 imposes discrete timeframes for specific testing methods: red cell antigen blood grouping within 6 days, human leucocyte antigen tissue typing within 3 days, and for DNA typing within "a reasonable time", and it separately requires that red cell enzyme blood grouping or serum markers be either tested or converted into a dried sample within 6 days.

Reporting responsibilities. Section 14 operationalises s 12(2) of the Act by specifying that the "relevant person" for a parentage testing procedure report is the nominated reporter for the report, together with either the person who carried out the testing or the person under whose supervision it was carried out. The Regulation thus apportions joint signature and completion duties on the approved form to both administrative and technical actors.

Repeal and transitional continuity. Section 15 repeals the former 2012 Regulation, and s 16 supplies a saving that references to the repealed regulation in documents can be read as references to this Regulation where the context permits.

Taken together, these concepts create a compliance architecture that links identity/consent, sterile sampling, tamper-evident handling, accredited laboratory procedures and prescribed reporting signatories into a legally enforceable chain intended to protect sample integrity and the reliability of parentage testing results.

Directly affected persons and entities are described in the Regulation’s operative provisions and definitions. The key classes are donors, relevant persons (which include consenting persons for minors and adults with impaired capacity), samplers, accredited laboratories and nominated reporters for the parentage testing procedure report. Each class has prescribed actions or constraints.

Donors. The Regulation requires that information and photographic identification for each donor be produced and attached to an affidavit in an approved form immediately before sampling (s 6). Donors who are adults with capacity are the "relevant person" for the affidavit and signing, unless the donor is a child or an adult with impaired capacity where a consenting person authorised under the Act stands in (s 6). Donors therefore bear the practical burden of providing identity evidence and of complying with the photographer/signing process immediately prior to sample collection.

Relevant persons for minors and adults with impaired capacity. Section 6 cross-references s 11(4)(b) and (c) of the Act to determine who may consent for children and adults with impaired capacity. The Regulation gives a central role to those persons in the pre-sampling authentication process, including signing the affidavit and the sample label and being present when the sample is placed in the container (ss 6, 9). That allocates verification and witnessing functions to the class of persons empowered under the Act to consent.

Samplers. Section 5 restricts sample-taking to a person who is a sampler. The Regulation imposes multiple duties on samplers: to obtain the affidavit and photographs and to ensure they are provided to the sampler before sampling (s 6); to use single-use, sterilised, disposable instruments for blood sampling and to clean skin with antiseptic (s 7); to use unused and sterilised swabs or implements for DNA-typing samples (s 8); to place the sample in an unused, tamper-evident container in the presence of a relevant person, to label and sign the label (s 9); to make a formal sampler statement in the approved form with the photograph attached and signed in the prescribed way (s 10); and to package and transport the sample to an accredited laboratory in a way that preserves integrity and ensures equivalence to immediate testing, and to send the affidavit and statement with the sample (s 11). Samplers therefore carry the central operational burden of statutory compliance during collection and handover.

Accredited laboratories. Sections 11, 12 and 13 place requirements on accredited laboratories. Laboratories must be accredited, must test under the accredited standards of practice for which the laboratory holds accreditation (s 12), and must carry out specified tests within prescribed timeframes or prepare a dried sample within 6 days for certain assays (s 13). Laboratories bear the obligations to meet and maintain accreditation, to manage workflow to meet timeframes, and to accept the required documentation with samples.

Nominated reporters and test performers/supervisors. Section 14 requires the nominated reporter for the parentage testing procedure report and either the person who carried out the testing or the person under whose supervision the testing was carried out to fill in and sign the parts of the report required by the approved form. This assigns dual responsibilities for completion and authentication of the laboratory report.

Third parties indirectly affected. The repeal clause in s 15 and the transitional provision in s 16 mean persons and institutions that refer to the 2012 Regulation in existing documents must review and, if necessary, update references. Also, while the Regulation is silent on penalties, enforcement and offence provisions may exist in the parent Act; persons responsible for compliance should consult the Act for enforcement consequences. The Regulation also presumes the existence of "approved forms" and an accreditation framework external to the instrument; entities that provide sampling, laboratory testing, administrative reporting and legal services will need to coordinate with whatever administrative instrument or agency issues the approved forms and accredits the laboratories.

Who decides. Decision authority is allocated as follows. The Act (not reproduced here) decides who may consent for minors and adults with impaired capacity, and that decision feeds into the Regulation’s "relevant person" rules (s 6). The sampling decision and immediate on-site procedural decisions are made by the sampler, subject to the requirement that the sampler be present and take particular steps in the presence of the relevant person (ss 5, 6, 9). Accredited laboratories decide the standards under which they operate, but testing must occur under those accredited standards (s 12). The nominated reporter, the person who carried out the test, and the supervising person have prescribed reporting duties (s 14). The Regulation does not itself specify who pays for sampling or testing, nor does it set fees or funding; those matters are outside the text.

The Regulation creates a set of mandatory duties. It does not specify civil rights or remedies, nor does it set out penalty provisions within its text. The duties are tightly specified and often procedural in form. Below are the principal duties with the regulation provisions cited.

Duty: only authorised persons may sample. Section 5 provides that a person must not take a sample for a parentage testing procedure unless the person is a sampler. This is a threshold gatekeeping rule.

Duty: obtain and process approved-form affidavit and photographs immediately before sampling. Section 6 requires that, immediately before the sampler takes the sample, a relevant person for an affidavit for the donor must: make an affidavit in the approved form, attach a recent photograph to the affidavit, sign partly on the photograph and partly on the affidavit in the way required by the approved form, and give the affidavit and another recent photograph to the sampler (s 6(1)(a)-(d)). The section defines "recent photograph" by reference to approved-form requirements and defines "relevant person" by reference to capacity and the Act’s consent rules (s 6(2)).

Duty: instrument hygiene and disposability for blood sampling. Section 7 mandates that instruments used to take blood are unused for any purpose, sterilised and disposable; and the area of skin must be cleaned with an antiseptic prior to the sample being taken (s 7(1)-(2)). The section defines "instrument" to include needle and syringe.

Duty: instrument hygiene for DNA typing. Section 8 requires swabs to be unused and sterilised and requires that skin scrapings and hair roots be taken with a sterilised implement (s 8(2)-(3)).

Duty: immediate placement, tamper-evident container and labelling. Section 9 requires immediate placement of the sample in a container in the presence of a relevant person (s 9(1)), that the container be unused and sealed in a tamper-evident way (s 9(2)), that labels be attached so that removal or alteration would be obvious (s 9(3)), and that the label be written in ink with the donor’s full name, sex and date of birth and the date and time of sampling, and signed in ink by the sampler and relevant person (s 9(4)-(5)).

Duty: sampler statement with photograph attached. Section 10 requires the sampler who took the sample to make a statement in the approved form, attach the photograph supplied under s 6(1)(d) to that statement, and sign partly on the photograph and partly on the statement in the manner required by the approved form (s 10).

Duty: preservation of integrity in storage, packing and transport, and sending key documents. Section 11 requires the sampler to ensure that the sample is stored, packed and transported to an accredited laboratory in a way that preserves the integrity of the sample and ensures testing will produce the same results as if conducted immediately after collection. The sampler must send the affidavit and the sampler’s statement to the accredited laboratory with the sample (s 11(1)-(2)).

Duty: testing only at accredited laboratories under accredited standards. Section 12 requires parentage testing procedures to be carried out at an accredited laboratory and under the standards of practice for which the laboratory holds accreditation (s 12(1)-(2)).

Duty: timing constraints for particular tests and preparation of dried samples. Section 13 requires accredited laboratories to ensure testing is carried out within specified periods: 6 days for red cell antigen blood grouping, 3 days for human leucocyte antigen tissue typing, and within a reasonable time for DNA typing. It also requires that where testing is red cell enzyme blood grouping or testing for serum markers, the laboratory must either carry out the test or prepare a dried sample within 6 days (s 13).

Duty: completion and signature of parentage testing procedure report by nominated reporter and test performer/supervisor. Section 14 requires that the relevant person(s) for the report as defined (the nominated reporter plus either the person who carried out the test or the person under whose supervision it was carried out) fill in and sign the parts of the report the approved form requires them to complete (s 14).

The Regulation also imposes indirect duties by reference. For example, the "relevant person" definition in s 6 references decision-making under the Act, specifically s 11(4)(b) and (c). Compliance therefore requires consultation with the Act to determine who may consent and who may sign for minors and adults with impaired capacity.

Rights and omissions. The Regulation does not itself specify private rights of action, administrative review pathways, or penalties for non-compliance. It does not identify expressly the legal consequences of failing to follow one of the procedural steps, nor does it define evidence admissibility in court. Those matters must be determined from the parent Act, other legislation, or common law. The Regulation’s silence on penalties means that duties exist but the mechanism for enforcement is not prescribed in the text provided. Practitioners should therefore consult the Act and any administrative instruments or guidelines for enforcement mechanisms.

The Regulation, as reproduced here, does not contain express penalty provisions nor a dedicated enforcement regime. It prescribes a series of mandatory procedural requirements using prohibitory language (for example, "must not" in ss 5, 7 and 8) and positive duties ("must" in ss 6, 9, 10, 11, 12, 13 and 14), but it does not attach fines, offences or administrative sanctions within its text. Where a statute prescribes mandatory obligations without specifying sanctions, the enforcement consequences may be located elsewhere, typically in the parent Act or in other relevant statutes. The Regulation itself cross-references the Act at multiple points, for example in s 6 when defining relevant persons by reference to s 11(4)(b) and (c) of the Act, and in s 14 where the reporting duty references s 12(2) of the Act. Enforcement mechanisms, including whether breach of these provisions is an offence, a ground for evidentiary exclusion, or a basis for administrative sanctions, must therefore be sought in the Act or other instruments.

Practical enforcement considerations arising from the Regulation’s content. Although the instrument contains no internal penalty clauses, it erects clear procedural markers that will have practical effects in administrative and legal contexts:

• Chain-of-custody and tamper-evident requirements. Sections 9 to 11 create documentary and physical markers (affidavit, photographs, sampler statement, sealed container, signed label) that will be relevant to a laboratory’s acceptance of a sample, to an issuing authority’s acceptance of a report, and to a court’s or tribunal’s assessment of evidentiary reliability. Non-compliance with these steps may lead to administrative rejection of a test result or to weight being given to gaps in chain-of-custody in subsequent proceedings, even if the Regulation itself does not specify the legal consequences.

• Accreditation reliance. Section 12 makes accredited status and testing under accredited standards a statutory precondition for lawful parentage testing. The accreditation status is therefore an enforcement hinge. Regulatory or administrative agencies that maintain or recognise accreditation schemes (the identity of which is not specified in the Regulation) will effectively hold leverage over lawful testing through accreditation decisions.

• Timeframe compliance. Section 13 imposes numerical time limits for certain assays and a "reasonable time" standard for DNA typing. Failure to meet these timeframes may be material when assessing whether the laboratory complied with regulatory duties, and may trigger administrative inquiries or contractual disputes between clients and laboratories.

Who enforces. The Regulation does not name an enforcement agency or provide a starting point for complaints. Enforcement could be by the entity responsible for administering the parent Act, by licensing or accreditation bodies for laboratories, or through courts if the Act supplies private or public enforcement mechanisms. For a final position on who may bring enforcement action, and what sanctions apply for non-compliance, practitioners must refer to the parent Act and any relevant administrative instruments that set out offence provisions, sanctions, or disciplinary processes.

Recordkeeping and admissibility. The Regulation compels the creation and transfer of particular documents (approved-form affidavits, sampler statements, photographs, labelled tamper-evident containers). Even where the Regulation does not prescribe penalties, failure to produce these documents may materially affect admissibility and the probative value of a parentage test result in legal proceedings. Practitioners should therefore treat the Regulation as setting minimum documentation standards for evidentiary quality.

The Regulation is explicitly cross-referential. It operates as a regulation subordinate to a parent Act (referred to as "the Act" in the text) and imports key definitions and consent rules from that Act. It also incorporates external instruments via references to "approved form" and to "accredited laboratory" and "standards of practice for which the laboratory holds accreditation". Those external instruments and frameworks are outside the Regulation and will be the loci of interaction with other legal regimes.

Direct statutory interactions in the text. The Regulation cross-references the Act at multiple points. Section 6 defines "relevant person" by reference to the Act’s s 11(4)(b) and (c) in order to determine who may consent for children or adults with impaired capacity. Section 14 implements s 12(2) of the Act by specifying who must complete and sign parts of the parentage testing procedure report. Practitioners must therefore read this Regulation in conjunction with the Act to identify consent rules, the legal status of parentage testing orders, and any sanctions that the Act enforces for non-compliance. These are direct statutory interactions.

Interaction with accreditation, laboratory and health regulation. Section 12 requires that parentage testing be conducted at an accredited laboratory and under the standards of practice for which the laboratory holds accreditation. The Regulation does not itself define accreditation criteria, accreditation bodies, or the content of those standards. In practice, accreditation and laboratory standards will be set by external bodies or laws governing health laboratories, pathology services, forensic services or similar. The Regulation therefore interacts with those bodies and instruments by making accreditation a statutory requirement for lawful testing. This creates a dependency: the Regulation defers specification of technical standards and quality assurance to the accreditation framework.

Interaction with evidence law and procedural law. The Regulation establishes detailed chain-of-custody and identification procedures. Those procedures, while not themselves dictating evidentiary rules, will influence the practical weight accorded to test results in court and tribunal proceedings. Failure to comply with the Regulation’s procedures may be relied upon by parties in litigation to challenge the admissibility or credibility of a test, even though the Regulation does not itself set evidentiary rules. The Regulation therefore interacts with common law and statutory evidence rules through the production or absence of required documentation and tamper-evident measures.

Interaction with capacity, consent and guardianship law. Section 6 imports the Act’s rules on who may consent for children and adults with impaired capacity. The practical consequence is that other laws determining capacity and guardianship (for example, jurisdictional guardianship or child welfare laws) may be relevant to identifying the correct "relevant person" who must make the affidavit and sign documents. Where the Act borrows or aligns with those other legal regimes, there will be a point of interaction that affects whether a sample was lawfully taken.

Transitional and archival interactions. Section 16 preserves references to the repealed 2012 regulation by allowing documents that refer to the repealed regulation to be read as references to the new regulation if the context permits. This gives continuity across instruments and interacts with archival documents, contracts and forms that were prepared under the old regulation.

What the Regulation does not do. It does not set out the accreditation scheme or approved forms, it does not specify sanctions or enforcement agencies, and it does not alter evidentiary rules directly. Those aspects will interact with other statutes, administrative instruments and accreditation frameworks outside the text. Practitioners should therefore treat this Regulation as a procedural overlay that specifies minimum steps for sample integrity and reporting, and should map those steps against the parent Act, applicable accreditation instruments, health and safety obligations and evidence rules in the relevant jurisdiction.

This Regulation is presented as Status of Children Regulation 2022 and its operative commencement date is 1 September 2022 (s 2). The Regulation contains an explicit repeal of the Status of Children Regulation 2012, SL No. 135 (s 15). The transitional provision in s 16 allows references in documents to the repealed 2012 regulation to be read as references to this regulation where the context permits.

From the text supplied, the amendment history within the instrument itself is minimal:

• Enactment and commencement. Short title provision is s 1, and s 2 fixes commencement on 1 September 2022. There are no internal amendments described in the text beyond repeal.

• Repeal of the predecessor regulation. Section 15 repeals the 2012 Regulation. The repeal means the 2012 instrument is no longer in force and is replaced by this Regulation as the operative instrument governing parentage testing procedures and related matters specified herein.

• Transitional saving. Section 16 provides for practical continuity by treating references to the repealed regulation in documents as references to the current Regulation, where context permits. This is a standard drafting device to reduce the need to amend legacy documents immediately.

No other amendments are recorded in the supplied text. There is no express schedule of transitional arrangements for samples collected under the 2012 Regulation but not yet tested, nor is there a phased compliance window specified. The only transitional step is the contextual preservation in s 16.

What you must check beyond this text. The text repeatedly refers to "approved form" and to "accredited laboratory", but does not contain those approved forms or the accreditation criteria. If those forms or accreditation arrangements were made or amended contemporaneously with this Regulation, they will be separate instruments. To trace a full amendment history in administrative practice, practitioners must consult the parent Act, any instrument(s) authorising the approved forms, and the accreditation body or instrument that defines accreditation status and standards. Also consult any instrument that implemented the 2012 Regulation, and its repeal notes, to map differences between the two regulations and to identify transitional operational changes that affected practitioners in the period immediately following 1 September 2022.

The Regulation as supplied contains no record of litigation, case references or judicial interpretations. It does not name any cases, nor does it include notes about judicial decisions applying its provisions. Because the instrument is procedural and defines steps for sampling and testing, litigation that could arise from its operation would likely involve evidentiary disputes, challenges to chain of custody, admissibility of parentage test results, or disputes over capacity and consent under the parent Act. None of those potential litigation themes are recorded in the Regulation text.

What practitioners should do to establish litigation risk or precedent. To determine litigation history and precedent relevant to the Regulation, consult:

• Judicial decisions that interpret the parent Act provisions the Regulation cross-references, for example the consent provisions in s 11(4)(b) and (c) and the reporting provisions in the Act’s s 12(2).

• Any case law dealing with the admissibility of parentage testing evidence where chain-of-custody, tamper-evidence, or laboratory accreditation was in dispute. While this Regulation institutionalises particular chain-of-custody requirements, courts may have existing jurisprudence that addresses similar factual issues.

• Administrative decisions or disciplinary outcomes involving laboratories that failed to meet accreditation standards or were the subject of regulatory action, where those outcomes illuminate how accreditation status and accredited standards are applied in practice.

The Regulation does not provide any consolidated litigation history, and no decisions are cited in the text. Practitioners should therefore search the case law databases and the administrative records relevant to the parent Act and to laboratory accreditation bodies for any authoritative interpretations or enforcement actions that have engaged these procedural requirements.

The Regulation contains a number of potential practical pitfalls, compliance traps and areas of uncertainty that practitioners and operational actors should notice. These are matters where literal compliance with the text requires attention to form, timing, documentation and external instruments.

Approved forms and the signature across photograph requirement. Sections 6 and 10 require an affidavit and a sampler statement in the approved form, and both require signing partly on a photograph and partly on the affidavit or statement "in the way required by the approved form" (ss 6(1)(c), 10). The Regulation does not reproduce the approved forms or specify precisely how the signature must run across documents and photograph. Practical risk: if the signed mode of affixing signatures differs from the approved form, a sampler may be non-compliant even though the signature is present. Practitioners must obtain and inspect the approved forms before sampling to ensure the cross-signature method and photograph specifications are followed.

Definition dependencies. The Regulation repeatedly uses defined terms that are located in Schedule 1 (s 3) and in the parent Act. For example, "sampler", "donor", "recent photograph", "approved form", "nominated reporter", "accredited laboratory", and "relevant person" may be subject to definition-specific constraints that materially affect who may act and how. Risk: assuming a colloquial meaning for "sampler" or "accredited laboratory" without checking Schedule 1 and the Act can produce non-compliance.

Stringent single-use and sterilisation rules. Sections 7 and 8 require instruments to have "not previously been used for any purpose", to be sterilised and disposable (s 7), and for swabs/implements to be unused and sterilised for DNA typing (s 8). These words are absolute. Practical consequence: re-using a device or using a non-disposable instrument even where it appears sterile is prohibited. Samplers and clinics must procure appropriate single-use disposables and maintain inventories. Risk: supply shortages, cost increases, or reliance on hospital stock that has been previously used may create compliance problems.

Immediate placement and witnessing requirements. Section 9 requires that the sample be placed in a container immediately after collection and in the presence of a relevant person. In contexts where a relevant person is not physically present, for example remote sampling arrangements, this rule may be impractical. The Regulation does not provide a remote-photographic or electronic witnessing alternative. Risk: remote sampling may be non-compliant unless an exception exists elsewhere in the Act or authorised forms.

Tamper-evident labelling and container requirements. Section 9 mandates tamper-evidence both in container sealing and in label attachment, and requires label entries in ink and signatures by sampler and relevant person after writing the information. Risk: failure to use an appropriately tamper-evident container or to get the relevant person’s on-label signature can break the chain-of-custody requirements.

Document transmission. Section 11 requires the sampler to send the approved-form affidavit and the sampler’s statement to the accredited laboratory with the sample. Failure to transmit these documents may render the sample and any report non-compliant under the Regulation, because the laboratory’s duty under s 12 to perform testing at an accredited laboratory "and" under its accredited standards may be interpreted to require receipt of the complete documentation packet. Risk: lost documents, incomplete transfers or electronic transmission without original forms may be problem areas.

Timeframe vagueness for DNA typing. Section 13 prescribes explicit days for some assays (6 and 3 days) but leaves DNA typing to "a reasonable time". The "reasonable time" standard is inherently indeterminate and may create disputes between laboratories and clients about what constitutes reasonable. Risk: disputes or complaints if testing timelines extend beyond client expectations. For red cell enzyme blood grouping and serum markers, the 6-day rule requires either testing or preparing a dried sample within 6 days; compliance requires operational capacity to either test quickly or prepare preserved dried samples.

Accreditation dependency. Sections 12 and 13 make accreditation and testing under accredited standards a statutory precondition. The Regulation does not define accreditation bodies or criteria. Risk: labs that lack the requisite accreditation for particular tests cannot lawfully perform them under the Regulation; parties ordering tests must verify the laboratory’s accreditation for the specific test and for the standards of practice under which the lab operates.

Absence of penalty clauses. The Regulation contains mandatory language but no internal enforcement clause. Risk: uncertain immediate legal consequences for non-compliance, and variable administrative responses depending on how the parent Act or accreditation bodies treat breaches.

Transitional reference pitfalls. Section 16 allows references to the 2012 Regulation to be read as references to this Regulation "if the context permits". Risk: documents that quote specific provisions, forms or processes from the 2012 regime may be ambiguous and may require explicit amendment to avoid interpretive disputes.

Practical checklist omissions. The Regulation assumes common-sense elements such as record retention durations, the details of packaging materials, courier chain-of-custody tracking requirements, and electronic reporting standards. These operational details are not specified. Practitioners must determine them locally and document them to demonstrate compliance.

In sum, the main gotchas are the dependence on approved forms and external accreditation rules that are not reproduced, strict single-use hygiene rules, precise physical signature requirements across photographs and forms, immediate witnessing obligations, specific labelling and tamper-evidence expectations, time limit vagueness for DNA typing, and the lack of explicit enforcement measures within the instrument. Compliance planning must therefore address these concrete practical requirements.

Compliance requires operationalising the Regulation’s procedural steps into a documented workflow that covers pre-sampling checks, sampling practice, immediate post-sampling actions, transport and laboratory handover, and reporting completion. Below is a step-by-step compliance checklist tied to the specific sections.

1. Establish authority to act as a sampler.

   • Confirm that persons taking samples meet the definition of "sampler" in Schedule 1 (s 3) and are authorised to take samples (s 5).
   • Maintain a roster or credential file that evidences who is authorised.

2. Secure and use the approved forms and photograph specifications.

   • Obtain the current approved form for the affidavit and the sampler statement, and the approved form for the parentage testing procedure report (ss 6, 10, 14).
   • Review the approved form to confirm the exact requirements for "recent photograph" and the required method of signing partly on the photograph and partly on the affidavit or statement (s 6(1)(b)-(c), s 10).
   • Train samplers and reception staff on the approved-form requirements and the cross-photograph signature technique.

3. Confirm the relevant person for consent and witnessing.

   • For each donor, determine whether the donor is an adult with capacity, a child under 16, or a child aged 16 or 17 with impaired capacity, or an adult with impaired capacity, and identify the person authorised to give consent under s 11(4)(b) and (c) of the Act as required by s 6.
   • Ensure the relevant person will be present at sampling to witness container placement and sign the sample label (s 9(1), s 9(5)).

4. Prepare and verify identity documentation prior to sampling.

   • Immediately before sampling, ensure a relevant person makes the approved-form affidavit, attaches a recent photograph that meets the approved-form requirements, signs partly on the photograph and partly on the affidavit in the required manner, and gives the affidavit and another recent photograph to the sampler (s 6(1)(a)-(d)).
   • Keep a checklist to confirm both photographs and the completed affidavit have been provided.

5. Acquire and use compliant sampling instruments and consumables.

   • For blood sampling, use instruments that have not previously been used for any purpose, are sterilised and disposable, and ensure the donor’s skin area is cleaned with an antiseptic immediately prior to sampling (s 7).
   • For non-blood DNA sampling, use swabs that are unused and sterilised, and use sterilised implements for skin scrapings and hair roots (s 8).
   • Maintain inventory controls and procurement policies to avoid accidental reuse.

6. Follow immediate container sealing and labelling procedure.

   • Place the sample in a container immediately after collection and in the presence of the relevant person (s 9(1)).
   • Use a container that has not previously been used for any purpose and that is sealed in a way that makes subsequent opening obvious on inspection (s 9(2)).
   • Attach a label whose removal or alteration would be obvious on inspection and write in ink the donor’s full name, sex and date of birth, and the date and time the sample was taken (s 9(3)-(4)).
   • After writing the label, have both the sampler and the relevant person sign the label in ink (s 9(5)).

7. Prepare the sampler’s statement and attach photograph.

   • Immediately after sampling, the sampler must make a statement in the approved form, attach the photograph provided under s 6(1)(d) to that statement, and sign partly on the photograph and partly on the statement in the way required by the approved form (s 10).

8. Preserve integrity in storage, packing and transport, and include required documentation.

   • Ensure the sample is stored, packed and transported in a manner that preserves sample integrity and ensures that testing will produce the same results as immediate testing (s 11(1)).
   • Send the affidavit in the approved form and the sampler’s statement in the approved form with the sample to the accredited laboratory (s 11(2)).
   • Implement chain-of-custody logs that record timestamps, handlers, transport conditions and custody transfers.

9. Verify laboratory accreditation and standards.

   • Before dispatching a sample, confirm that the receiving laboratory is accredited and holds accreditation for the relevant tests and standards of practice (s 12).
   • Obtain and retain documentation of the laboratory’s accreditation status for the specific tests to be performed and verify that the laboratory will carry out testing under the standards for which it is accredited (s 12).

10. Monitor testing timeframes and prepare dried samples where required.

    • For red cell antigen blood grouping, ensure testing is arranged to be carried out within 6 days of sampling (s 13(1)(a)).
    • For human leucocyte antigen tissue typing, ensure testing is carried out within 3 days (s 13(1)(b)).
    • For red cell enzyme blood grouping and serum markers, ensure the laboratory either carries out testing or prepares a dried sample for later testing within 6 days of sampling (s 13(2)).
    • For DNA typing, establish service-level expectations with the laboratory for what will constitute a "reasonable time" and document those expectations.

11. Complete and sign the parentage testing procedure report per the approved form.

    • The nominated reporter for the parentage testing procedure report must fill in and sign the parts of the report required by the approved form (s 14).
    • Either the person who carried out the parentage testing procedure or the person under whose supervision it was carried out must also fill in and sign their part(s) of the report (s 14).
    • Maintain copies of completed reports and signatory evidence.

12. Record retention and audit readiness.

    • Retain originals or certified copies of affidavits, photographs, sampler statements, labelling, chain-of-custody logs and completed reports in a secure, auditable recordkeeping system.
    • Keep records in accordance with retention periods mandated under the parent Act or other applicable law, and in any case sufficient to demonstrate compliance with the Regulation.

13. Review and update forms and policies upon repeal transition.

    • Replace references to the 2012 Regulation with references to this Regulation in policies, forms, contracts and guidance documents, taking advantage of the transitional provision in s 16 where appropriate.
    • Update procurement, sampling and transport SOPs to reflect single-use and tamper-evidence requirements.

14. Train and audit staff.

    • Provide training and competency checks for samplers on the approved-form signing method, instrument use, antiseptic procedures, labelling and chain-of-custody transfers.
    • Conduct internal audits that check for presence of approved forms, photographs, signed labels, sampler statements and evidence that required documents were sent to the laboratory.

15. Liaise with accreditation bodies and legal advisors.

    • Confirm the precise accreditation criteria and permitted standards with the accreditation body to ensure the laboratory meets the Regulation’s requirement that testing be carried out under the standards for which the laboratory holds accreditation (s 12).
    • Seek legal advice about enforcement consequences, admissibility implications and the parent Act’s consent and penalty provisions, because the Regulation itself does not specify penalties (see the Penalties and enforcement section).

By converting each regulatory step into documented SOPs, checklists and training modules, and by securing the approved forms and laboratory accreditation confirmations, organisations can create a defensible compliance posture. The main operational risks relate to ensuring approved-form compliance (particularly the signature-across-photograph requirement), maintaining supply of single-use instruments and tamper-evident containers, and managing time-limited assays in coordination with accredited laboratories.